While most men with prostate cancer can be successfully treated, when the disease metastasizes to the bone, it eventually becomes lethal. In a study published online December 1st in the journal iCancer Research,/i researchers show that the receptor CCR5 best known for its role in HIV therapy, may also be involved in driving the spread of prostate cancer to the bone. "Because this work shows we can dramatically reduce metastasis in pre-clinical models, and because ...
Read MoreYou have just read an article categorized health
titled Bone Metastases in Prostate Cancer Blocked by HIV Drug.
Written by:
editor - Monday, December 1, 2014
There are currently no comments for "Bone Metastases in Prostate Cancer Blocked by HIV Drug"
Post a Comment